关注
Mei Ling Chong
Mei Ling Chong
Associate Research Scientist
在 yale.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Evidence for functional redundancy of class IA PI3K isoforms in insulin signalling
C Chaussade, GW Rewcastle, JD Kendall, WA Denny, K Cho, ...
Biochemical Journal 404 (3), 449-458, 2007
2622007
Response to a novel multitargeted tyrosine kinase inhibitor pazopanib in metastatic Merkel cell carcinoma
M Davids, A Charlton, SS Ng, ML Chong, K Laubscher, M Dar, J Hodge, ...
Journal of Clinical Oncology 27 (26), e97-e100, 2009
1012009
Phosphatidylinositol‐3‐kinase pathway aberrations in gastric and colorectal cancer: Meta‐analysis, co‐occurrence and ethnic variation
ML Chong, M Loh, B Thakkar, B Pang, B Iacopetta, R Soong
International journal of cancer 134 (5), 1232-1238, 2014
452014
Immature murine NKT cells pass through a stage of developmentally programmed innate IL-4 secretion
N Dickgreber, KJ Farrand, N van Panhuys, DA Knight, SJ McKee, ...
Journal of leukocyte biology 92 (5), 999-1009, 2012
232012
TFG-RARA: A novel fusion gene in acute promyelocytic leukemia that is responsive to all-trans retinoic acid
ML Chong, H Cheng, P Xu, H You, M Wang, L Wang, HH Ho
Leukemia research 74, 51-54, 2018
162018
Acquired resistance to combination treatment through loss of synergy with MEK and PI3K inhibitors in colorectal cancer
B Bhattacharya, SHH Low, ML Chong, D Chia, KX Koh, NS Sapari, ...
Oncotarget 7 (20), 29187, 2016
42016
Integrated exome sequencing and microarray analyses detected genetic defects and underlying pathways of hepatocellular carcinoma
ML Chong, J Knight, G Peng, W Ji, H Chai, Y Lu, S Wu, P Li, Q Hu
Cancer Genetics 276, 30-35, 2023
12023
Activity of BAY1082439, a balanced PI3Kα/β inhibitor, in gastric cancer
HT Hung, R Ong, K Haike, E Petrova, ML Chong, M Loh, B Bhattacharya, ...
Cancer Research 75 (15_Supplement), 2674-2674, 2015
12015
Characterising Somatic Mutations in Cancer Genome by Means of Next-generation Sequencing
ML Chong, CS Ku, M Wu, R Soong
eLS, 2012
12012
Acquired Ring Chromosomes in Solid Tumors
J Wen, ML Chong
Human Ring Chromosomes: A Practical Guide for Clinicians and Families, 475-490, 2024
2024
Ring Chromosome 19
J Wen, ML Chong
Human Ring Chromosomes: A Practical Guide for Clinicians and Families, 271-278, 2024
2024
Ring Chromosome 13
P Li, ML Chong
Human Ring Chromosomes: A Practical Guide for Clinicians and Families, 201-214, 2024
2024
Patterns of Cytogenomic Findings from a Case Series of Recurrent Pregnancy Loss Provide Insight into the Extent of Genetic Defects Causing Miscarriages
A DiAdamo, H Chai, ML Chong, G Wang, J Wen, YH Jiang, P Li
Global Medical Genetics 11 (01), 123-131, 2024
2024
71. Integrated genomic analysis of hepatocellular carcinoma using WES and aCGH
ML Chong, H Chai, Q Hu, P Li
Cancer Genetics 278, 22, 2023
2023
Determinants of sensitivity to PI3K inhibitors in PIK3CA wildtype gastric tumor cells
ML Chong, B Bhattacharya, D Voon, KX Koh, HH Low, TL Chang, M Wu, ...
Cancer Research 75 (15_Supplement), 2655-2655, 2015
2015
Abstract B02: Determinants of acquired resistance to combination treatment with MEK and PI3K inhibitors
B Bhattacharya, S Low, D Chia, KX Koh, ML Chong, T Benoukraf, ...
Clinical Cancer Research 21 (4_Supplement), B02-B02, 2015
2015
74 Increased EDN1 expression mediates acquired resistance to the combination therapy of PI3K and MEK inhibitors for colorectal cancer
B Bhattacharya, SHH Low, T Benoukraf, ML Chong, KX Koh, R Soong
European Journal of Cancer, 29, 2014
2014
KRAS mutation analysis in a complex molecular diagnostic referral practice: the need for test redundancy
B Pang, CW Ong, ML Chong, T Muliana-Ismail, R Soong, M Salto-Tellez
Pathology-Journal of the RCPA 44 (7), 655-657, 2012
2012
系统目前无法执行此操作,请稍后再试。
文章 1–18